Alyeska Investment Group’s GoodRx Holdings GDRX Stock Holding History

Alyeska Investment Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500,000	Closed	-$2.96M	–	421
2022 Q2	$2.96M	Hold	500,000	–	–	0.03%	354
2022 Q1	$9.66M	Sell	500,000 -50,000	-9%	-$1.15M	0.11%	212
2021 Q4	$18M	Buy	550,000 +25,000	+5%	+$1.01M	0.21%	144
2021 Q3	$21.5M	Hold	525,000	–	–	0.27%	110
2021 Q2	$18.9M	Buy	525,000 +150,000	+40%	+$5.54M	0.22%	134
2021 Q1	$14.6M	Buy	375,000 +6,119	+2%	+$275K	0.19%	152
2020 Q4	$14.9M	Buy	368,881 +16,081	+5%	+$739K	0.21%	151
2020 Q3	$19.6M	Buy	+352,800	New	+$18.7M	0.3%	107

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Alyeska Investment Group's GDRX Position: Q3 2022 in Review

Alyeska Investment Group sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 500,000 shares — an estimated $2.96M sold.

Alyeska Investment Group first reported a position in GDRX in Q3 2020 and held it in 8 quarters. The position peaked at $21.5M in Q3 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

Alyeska Investment Group reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
Alyeska Investment Group sold 500,000 GoodRx Holdings shares in Q3 2022, an estimated $2.96M.
Alyeska Investment Group first reported a position in GoodRx Holdings in Q3 2020 and held it in 8 quarters.
Alyeska Investment Group's GoodRx Holdings position peaked at $21.5M in Q3 2021.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.